Navigation
Home
Advocating for Access
Background
Letters for Access
Press Releases For Access
Simplified Community Materials
Simplified Community Materials
Understanding your HCV infection
Community Led Reports
Country Information
Indonesia
India
Vietnam
Generic DAAs Pricing
Resources
Guidelines
Key Research Publication
Other Important Documents and Reports
News
Gallery
Photos
Video
Stories
Updated WHO screening, care and treatment of persons with hepatitis C infection_ April 2016.
Updated WHO screening, care and treatment of persons with hepatitis C infection_ April 2016.
Download PDF
April 18, 2016
/
News
Related
Posts
Generic daclatasvir (60 mg) availability and India market pricing as of 30 January 2016
Patent Situation of The Key Product For Treatment of Hepatitis C: SOFOSBUVIR – WHO working paper, updated 2015
Updated Patent Situation on Key Products for Hepatitis C Treatment in Asia – August 2015
Simplified HCV Treatment* for Treatment-Naive Patients Without Cirrhosis
Response from CEO, CHAI about the Quick Start program in November 2016
Rapid reductions in prices for generic sofosbuvir and daclatasvir to treat hepatitis C
Patient Groups and CSOs in Asia written a letter to Indian Government to Request Waiver on Local Clinical Trial for The Coming Generic DAAs
The use of generic DAAs for hepatitis C treatment, Freeman et al 2016
